Jerome Stevens Pharmaceuticals, Inc. Discontinued
FDA Approved Drugs

Jerome Stevens Pharmaceuticals, Inc. Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 17
  • Latest Approval Date Dec 02, 2021
  • Data Source FDA
  • First Approval Date Mar 17, 1988
All
33
View
Discontinued
17
View
RX
16
View
Company Overview

Company

Jerome Stevens Pharmaceuticals, Inc. Discontinued

Country

U.S.A

Social Profiles

Company Snapshot

Jerome Stevens Pharmaceuticals, Inc. Discontinued

JEROME STEVENS PHARMACEUTICALS, INC. 60 DAVINCI DR. BOHEMIA, NY 11716

U.S.A

www.unithroid.com/ INQUIRIES@JEROMESTEVENS.COM View on Map
FDA Approved Drug Records ( 17 records )
1988
17 Mar
Discontinued Application: 62869

Drug Name

CEPHALEXIN

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

1988-03-17

62869 / 1

Active Ingredient

CEPHALEXIN

Application Number

62869

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

1988-03-17

Regulatory Status

Discontinued

1988
17 Mar
Discontinued Application: 62870

Drug Name

CEPHALEXIN

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

1988-03-17

62870 / 1

Active Ingredient

CEPHALEXIN

Application Number

62870

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

1988-03-17

Regulatory Status

Discontinued

2021
02 Dec
Discontinued Application: 204364

Drug Name

CINACALCET HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2021-12-02

204364 / 1

Active Ingredient

CINACALCET HYDROCHLORIDE

Application Number

204364

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2021-12-02

Regulatory Status

Discontinued

2021
02 Dec
Discontinued Application: 204364

Drug Name

CINACALCET HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2021-12-02

204364 / 2

Active Ingredient

CINACALCET HYDROCHLORIDE

Application Number

204364

Product Number

2

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2021-12-02

Regulatory Status

Discontinued

2021
02 Dec
Discontinued Application: 204364

Drug Name

CINACALCET HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 90MG BASE

Approval Date

2021-12-02

204364 / 3

Active Ingredient

CINACALCET HYDROCHLORIDE

Application Number

204364

Product Number

3

Dosage Form

-

Strength

EQ 90MG BASE

Approval Date

2021-12-02

Regulatory Status

Discontinued

2019
27 Dec
Discontinued Application: 210727

Drug Name

DEFERASIROX

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2019-12-27

210727 / 1

Active Ingredient

DEFERASIROX

Application Number

210727

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2019-12-27

Regulatory Status

Discontinued

2019
27 Dec
Discontinued Application: 210727

Drug Name

DEFERASIROX

Product Number

2

Dosage Form

-

Strength

360MG

Approval Date

2019-12-27

210727 / 2

Active Ingredient

DEFERASIROX

Application Number

210727

Product Number

2

Dosage Form

-

Strength

360MG

Approval Date

2019-12-27

Regulatory Status

Discontinued

2020
15 Jun
Discontinued Application: 210727

Drug Name

DEFERASIROX

Product Number

3

Dosage Form

-

Strength

180MG

Approval Date

2020-06-15

210727 / 3

Active Ingredient

DEFERASIROX

Application Number

210727

Product Number

3

Dosage Form

-

Strength

180MG

Approval Date

2020-06-15

Regulatory Status

Discontinued

2018
25 May
Discontinued Application: 206787

Drug Name

ELETRIPTAN HYDROBROMIDE

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2018-05-25

206787 / 1

Active Ingredient

ELETRIPTAN HYDROBROMIDE

Application Number

206787

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2018-05-25

Regulatory Status

Discontinued

2018
25 May
Discontinued Application: 206787

Drug Name

ELETRIPTAN HYDROBROMIDE

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2018-05-25

206787 / 2

Active Ingredient

ELETRIPTAN HYDROBROMIDE

Application Number

206787

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2018-05-25

Regulatory Status

Discontinued

1995
31 Jan
Discontinued Application: 81145

Drug Name

METHOCARBAMOL AND ASPIRIN

Product Number

1

Dosage Form

-

Strength

325MG;400MG

Approval Date

1995-01-31

81145 / 1

Active Ingredient

ASPIRIN; METHOCARBAMOL

Application Number

81145

Product Number

1

Dosage Form

-

Strength

325MG;400MG

Approval Date

1995-01-31

Regulatory Status

Discontinued

2000
23 Jun
Discontinued Application: 40368

Drug Name

ORPHENADRINE CITRATE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2000-06-23

40368 / 1

Active Ingredient

ORPHENADRINE CITRATE

Application Number

40368

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2000-06-23

Regulatory Status

Discontinued

1999
30 Apr
Discontinued Application: 74988

Drug Name

ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE

Product Number

1

Dosage Form

-

Strength

385MG;30MG;25MG

Approval Date

1999-04-30

74988 / 1

Active Ingredient

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Application Number

74988

Product Number

1

Dosage Form

-

Strength

385MG;30MG;25MG

Approval Date

1999-04-30

Regulatory Status

Discontinued

1999
30 Apr
Discontinued Application: 74988

Drug Name

ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE

Product Number

2

Dosage Form

-

Strength

770MG;60MG;50MG

Approval Date

1999-04-30

74988 / 2

Active Ingredient

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Application Number

74988

Product Number

2

Dosage Form

-

Strength

770MG;60MG;50MG

Approval Date

1999-04-30

Regulatory Status

Discontinued

2018
31 Oct
Discontinued Application: 210738

Drug Name

VARDENAFIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2018-10-31

210738 / 1

Active Ingredient

VARDENAFIL HYDROCHLORIDE

Application Number

210738

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2018-10-31

Regulatory Status

Discontinued

2018
31 Oct
Discontinued Application: 210738

Drug Name

VARDENAFIL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2018-10-31

210738 / 2

Active Ingredient

VARDENAFIL HYDROCHLORIDE

Application Number

210738

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2018-10-31

Regulatory Status

Discontinued

2018
31 Oct
Discontinued Application: 210738

Drug Name

VARDENAFIL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2018-10-31

210738 / 3

Active Ingredient

VARDENAFIL HYDROCHLORIDE

Application Number

210738

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2018-10-31

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    14 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    33 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
17 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

CEPHALEXIN

Application Number

62869

Product Number

1

Active Ingredient

CEPHALEXIN

Dosage Form

-

Strength

EQ 500MG BASE

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.